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Background: Emotion (dys)regulation as well as the interventions for improving these 
difficulties are receiving a growing attention in the literature. The aim of the present paper 
was to conduct a systematic review about the efficacy of mindfulness-based interven-
tions (MBIs) in both substance and behavioral addictions (BAs).
method: A literature search was conducted using Cochrane, PubMed, and Web of 
Science. Fifty-four randomized controlled trials published in English since 2009 to April 
2017 were included into a narrative synthesis.
Results: Mindfulness-based interventions were applied in a wide range of addictions, 
including substance use disorders (from smoking to alcohol, among others) and BAs 
(namely, gambling disorder). These treatments were successful for reducing dependence, 
craving, and other addiction-related symptoms by also improving mood state and emotion 
dysregulation. The most commonly used MBI approaches were as follows: Mindfulness-
Based Relapse Prevention, Mindfulness Training for Smokers, or Mindfulness-Oriented 
Recovery Enhancement, and the most frequent control group in the included studies was 
Treatment as Usual (TAU). The most effective approach was the combination of MBIs 
with TAU or other active treatments. However, there is a lack of studies showing the 
maintenance of the effect over time. Therefore, studies with longer follow-ups are needed.
conclusion: The revised literature shows support for the effectiveness of the MBIs. 
Future research should focus on longer follow-up assessments as well as on adoles-
cence and young population, as they are a vulnerable population for developing prob-
lems associated with alcohol, drugs, or other addictions.
Keywords: mindfulness, addiction, behavioral addiction, substance use, gambling
iNtRODUctiON
Nowadays, the incidence of behavioral addictions (BAs), such as gambling disorder, internet addic-
tion, or compulsive buying, is increasingly important, even though substance use disorders (SUDs) 
are still the most prevalent addictions (1–6). BAs do not involve substance use but they share many 
core clinical features with substance addictions. In fact, in the latest version of the Diagnostic and 
Statistical Manual of Mental Disorders (7), gambling disorder appears in the “substance-related and 
addictive disorders” chapter, together with SUDs.
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Lifetime prevalence rates of SUDs are estimated to be around 
35.3% in the general population (8–10). When considering BAs 
these rates increase considerably (11). Moreover, addiction and 
other mental problems (especially mood and anxiety disorders) 
tend to often co-occur, maybe because the use of substances 
can actually induce mental disorders (12, 13) or because it 
can be a strategy of self-medication or simply an independent 
comorbid disorder. This situation generates an impairment in 
occupational and social functioning, as well as medical and 
legal problems. SUDs and BAs are characterized by the pres-
ence of a set of symptoms including tolerance, withdrawal, 
continued use despite wishes to stop, and despite knowing the 
negative consequences, a loss of regulatory control over drug 
cravings and further drug use [DSM-5 (7)]. Furthermore, crav-
ing, defined as “intense desire for drugs or addictive behaviors,” 
was added as diagnostic criteria and considered a key feature of 
emotion regulation that can affect drug use (10). Thus, SUDs 
are frequently associated with emotion regulation deficits and 
there seems to be a relationship between the severity of these 
deficits and higher drug use. However, the emotion dysregula-
tion observed in addictions is not only described as an ongoing 
maintenance factor for drug use but also an early risk factor.
Following to Gross (14), “emotion regulation refers to the 
process of shaping the emotions that one has, when one has 
them, and how one experiences or expresses these emotions.” 
There are three core features of emotion regulation. First, there is 
an activation of a goal to modify the emotion-generative process 
(15, 16); second, it produces an engagement of the processes 
that are responsible for altering the emotion trajectory; and 
third, there is an impact on emotion dynamics (16, 17). Given 
the importance of this construct in addictions and in view of the 
current treatment limitations when approaching emotion (dys)
regulation, other therapies have emerged for this aim includ-
ing Mindfulness-based Relapse Prevention (18), Mindfulness 
Training (MT) for Smokers (MTS) (19), or Mindfulness-
Oriented Recovery Enhancement [MORE (20)], and other 
therapies have been adapted to this population [e.g., Acceptance 
and Commitment Therapy, ACT (21)], Dialectical Behavior 
Therapy (22), or Mindfulness based Cognitive Therapy (23). 
MT represents the secular adaptation of Buddhist contemplative 
practices aimed to reduce suffering and foster well-being (24). 
Mindfulness has been described as “the awareness that arises 
from paying attention on purpose, in the present moment and 
non-judgementally to things as they are” [(25), p. 47] and unlike 
distraction, it is characterized by acceptance rather than with-
drawal from aversive emotional experience (26).
The aim of this study is to conduct a systematic review of 
the efficacy of the mindfulness-based interventions (MBIs) in 
SUDs and BAs by focusing on randomized controlled trials. This 
review is necessary due to the inclusion of both behavioral and 
chemical addictions.
metHODS
This systematic review was conducted and reported in accord-
ance with the Preferred Reporting Items for Systematic reviews 
and Meta-Analyses guidelines (27–29).
Search Resources
Two independent reviewers conducted the literature search, 
includ ing different sources such as electronic databases (Cochrane, 
PubMed, and Web of Science), citations, and reference lists, as well 
as gray literature. In addition, the reference lists of all included 
studies were hand searched, limiting the search to articles pub-
lished in English. To ensure that articles were recent, the search 
was focused in trials published from 2009 to April 30, 2017.
The search terms used were a combination of MESH terms and 
keywords and included “mindfulness addiction,” “mindfulness 
based relapse prevention,” “mindfulness impulsivity,” “mindfulness 
substance abuse,” “mindfulness substance use,” “MBRP,” “mindful-
ness gambling disorder,” “mindfulness pathological gambling” in 
the title, abstract, or keywords.
eligibility criteria
Eligibility criteria for the included studies were as follows: (1) 
to investigate the efficacy of MBIs in the samples of participants 
suffering from addictions, (2) inclusion of all ages, (3) to pro-
vide quantitative data supported by statistical methodology, (4) 
inclusion of a control group not receiving MBIs, (5) published in 
English, and (6) randomized controlled trials. Exclusion criteria 
were as follows: (1) quasi-experimental reports, (2) qualitative 
reports, (3) case reports, and (4) reviews (literature, systematic) 
and meta-analyses.
Mindfulness-based interventions were defined as a treatment 
addressed to promote the moment-by-moment awareness of 
thoughts, feelings, bodily sensations, and surrounding environ-
ment. It also involves acceptance, paying attention to thoughts 
and feelings without judging them.
Study Selection
First, all included studies were screened based on their titles and 
abstracts by two reviewers. Second, the identified studies in this 
search were distributed between five reviewers. The extracted 
information was checked by one reviewer. The relevant studies 
were discussed in the case of a disagreement between reviewers.
Data items
The extracted information from each included trial was as fol-
lows: (1) characteristics of the participants (including gender, age, 
and diagnosis) and the inclusion and exclusion criteria; (2) type 
of intervention (including type, frequency, and duration; versus 
non-mindfulness intervention; or versus no treatment); (3) type 
of outcome measure (including validated scales for measuring 
and main related results); (4) length of follow-up; (5) dropout 
rates; and (6) limitations of these studies (see Appendix S1 and 
S2 in Supplementary Material).
Because of the variability between studies (e.g., heterogeneity 
of participants, interventions, and reported outcome measures), 
this systematic review focuses on describing these trials, their 
results, their applicability, and their limitations and on narrative 
synthesis rather than on conducting a meta-analysis.
Outcome measures
The primary outcome measure was the difference between MBIs 
and no MBIs on measures of reduction of addiction-related 
FiGURe 1 | Preferred Reporting Items for Systematic reviews and Meta-Analyses flow chart of literature search.
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symptoms. Secondary outcome measures included changes 
in (1) self-reported mindfulness levels, (2) emotional self- 
regulation, (3) miscellaneous outcome measures, and (4) drop-
out rates.
Findings are classified according to the specific addiction 
being explored in each study.
Risk of Bias in individual Studies
For substantiating the validity of the eligible randomized trials, 
two reviewers worked independently and reliably to determine 
the adequacy of randomization and concealment of allocation, 
blinding of patients, data collectors, loss to follow-up, and other 
sources of bias.
ReSULtS
Study Selection and Design
The initial search identified 2,271 independent articles (see 
Figure  1 for the study selection flow chart). After removing 
duplicated and screened records, 69 full-text articles were 
assessed for eligibility and 15 of them were excluded for several 
reasons (e.g., no-randomized and/or controlled trials, reviews, 
no-mindfulness interventions, no addiction, or without included 
results). Finally, 54 articles met the criteria for inclusion and 
narrative synthesis (see Appendix S1 and S2 in Supplementary 
Material). All 54 studies finally selected for the review were 
randomized controlled trials published in English. The quality of 
these trials was evaluated.
Mindfulness interventions were applied in a wide range of 
addictions both in SUDs and BAs (e.g., gambling disorder). The 
majority of these studies focused on heterogeneous substance 
use, followed by studies on cigarette smoking, alcohol, opioids, 
gambling disorder, stimulants, marijuana, combination of cocaine 
and alcohol, and combination of tobacco and alcohol.
Study characteristics
Participants
The included studies involved 4,916 participants. The mean 
age of the participants was 34.95, and it was obtained from 51 
out of the 54 studies because three trials did not provide age 
data (30–32). In 50 studies (out of 54), 57.89% were men and 
42.11% were women. Four studies did not provide gender data 
(31, 33–35), five studies included only females (36–40) and six 
studies only males (41–46). Moreover, the target population of 
two studies was adolescence (47, 48) and of seven studies were 
young adults or college students (32, 34, 42, 44, 49–51). One 
trial (52) was focused on individuals with mild intellectual 
disabilities.
On the one hand, the most common inclusion criteria were 
(1) 18 years old or older; (2) English fluency; (3) meeting diag-
nostic criteria for SUD and other BAs (e.g., gambling disorder); 
(4) medical clearance; and (5) willingness to be randomized. 
However, several trials showed other or different inclusion 
criteria: (1) residency at the treatment center or therapeutic 
community (20, 30, 37); (2) to be able to speak and read Persian 
(53); (3) to be 18–29 (40, 50), 18–20 (42), 14 or older (48), 18–40 
taBLe 1 | Relation of the main included mindfulness-based interventions (MBIs) 
in the search literature and the type of related addiction.




Bowen et al. (70) Substance use 
disorder (SUD)
Brewer et al. (19) Cocaine and 
alcohol
Carroll (71) SUD
Chawla et al. (60) SUD
Hsin Hsu et al. (61) SUD
Lee et al. (45) SUD
Glasner-Edwards et al. (72) Stimulants
Glasner et al. (76) Stimulants
Witkiewitz and Bowen (68) SUD
Witkiewitz et al. (36, 69) SUD
Witkiewitz et al. (37) SUD
Witkiewitz et al. (36, 69) SUD
Zemestani and Ottavia (53) SUD
Mindfulness Training  
for Smokers
Brewer et al. (73) Tobacco
Davis et al. (50) Tobacco and 
alcohol
Davis et al. (55) Tobacco
Davis et al. (74) Tobacco
Kober et al. (75) Tobacco
Mindfulness-Oriented  
Recovery Enhancement
Garland et al. (20) Alcohol
Garland et al. (30) Alcohol
Garland et al. (56) Opioid
Garland et al. (57) Opioid
Garland et al. (43) SUD
Acceptance and  
Commitment Therapy
Bricker et al. (64) Tobacco
Dixon et al. (42) Gambling disorder
Luoma et al. (62) SUD
Smallwood et al. (66) Opioid
Yoga Butzer et al. (47) SUD
Butzer et al. (47) SUD
Fishbein et al. (48) SUD
Hallgren et al. (31) Alcohol
Mindfulness-Based  
Stress Reduction
Reza and Hosseinalipour (46) Opioid
Vidrine et al. (77) Tobacco
Mindfulness-Based 
Addiction Treatment
Vidrine et al. (78) Tobacco
Mind-Body Bridging Nakamura et al. (38) SUD
Mindfulness-Based  
Group Therapy
Imani et al. (33) Opioid
Integrative Body-Mind 
Training
Tang et al. (34) Tobacco
Mindfulness Based 
Substance Abuse  
Treatment
Himelstein et al. (44) SUD
Mindfulness-enhanced 
Cognitive Behavior  
Therapy




Azizi et al. (41) SUD
Affect Regulation Training Stasiewicz et al. (80) Alcohol
Mindful Awareness in  
Body-oriented Therapy
Price et al. (39) SUD
Mindfulness Based 
Cognitive Therapy
Negrei et al. (35) SUD
(Continued )
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(33), 20–45 (41), and 21–29  years old (54); (4) living in low 
socioeconomic areas (55); (5) recurrent pain (56, 57); (6) adult 
with mild intellectual disability (52), and (7) having participated 
in a school-based intervention program (58). Furthermore, there 
were studies which did not provide these data (35, 44, 47, 59–63). 
On the other hand, the main exclusion criteria were (1) psychosis 
or other severe psychiatric disorders (e.g., bipolar disorder), 
(2) dementia, and (3) suicide risk. Nineteen trials did not provide 
the exclusion criteria (20, 30, 35–37, 42, 44, 46, 47, 49, 52, 54, 
55, 60, 62, 64–67).
Intervention
The most frequent mindfulness interventions (Table  1) were 
MBRP (19, 36, 37, 45, 53, 60, 61, 68–72), MTS (50, 55, 73–75), 
MORE (20, 30, 43, 56, 57), ACT and variations (42, 62, 64, 66), 
and different types of Yoga (31, 47, 48).
Almost all interventions were composed of 7–12 weekly ses-
sions with a duration of 1–3 h per session, were guided by two 
therapists, and were performed in a group format. Eight studies 
showed different characteristics. First, Bricker et al. (64) used a 
smartphone app-delivered ACT intervention for smoking cessa-
tion. Second, Fishbein et al. (48), Nakamura et al. (38), Butzer 
et al. (47), and Vinci et al. (51) implemented more intensive inter-
ventions (e.g., between 20 and 32 sessions). In third and last place, 
three trials conducted a single session intervention (32, 49, 54). 
In addition, two studies (52, 65) did not explain the characteristics 
of their interventions.
Comparator
The most frequently used control group in the included studies 
was Treatment as Usual (TAU) (31, 33, 38, 39, 44, 45, 48, 52, 53, 
58–63, 68, 69, 77). Two studies (70, 71) compared MBRP with 
Relapse Prevention (RP) and TAU; and two studies more (36, 37) 
compared MBRP with RP. Cognitive Behavioral Treatment (19), 
Health Education [HE (66, 72, 76, 80)], Freedom from Smoking 
[FFS (73, 75)], Quit Line (74), Interactive Learning for Smokers 
[ILS (50)], Support Group [SG (20, 30, 56, 57)], a QuitGuide app 
(64), Physical Education (47), relaxation (34), medication treat-
ment (naltrexone or others) (35, 41), and suppression (65) were 
other comparators. Several trials used two control groups: FFS 
and Quit Line Intervention (55), CBT and TAU (43, 78), relaxa-
tion and puzzle group (51, 67), distraction strategy and passive 
control (54), and TAU and healthy controls (32). Finally, six trials 
(40, 42, 46, 49, 79, 81) did not administer any treatment in the 
control groups (waiting list).
Outcomes
Primary
In the majority of studies, the primary outcome assessed was 
substance use (severity, abstinence, and craving). Chawla et  al. 
(60) evaluated the adherence and competence of the intervention. 
Brain activation patterns and subjective ratings of slot machine 
outcomes during the fMRI tasks were the primary outcomes 
in the study by Dixon et  al. (42), as well as in the studies by 
Toneatto et  al. (79) and McIntosh et  al. (63) gambling severity 
and urges were the primary outcomes. Smallwood et  al. (66) 
assessed ACT in pain and addiction comorbidity using fMRI to 




Alterman et al. (59) SUD
Vinci et al. (51) Alcohol
Bowen and Marlatt (49) Tobacco
Rogojanski et al. (65) Tobacco
Singh et al. (52) Tobacco
Murphy and MacKillop (54) Alcohol
Vernig and Orsillo (32) Alcohol
McIntosh et al. (63) Gambling disorder
Vinci et al. (67) Alcohol
Harris et al. (58) Alcohol
Valls-Serrano et al. (81) SUD
de Dios et al. (40) Marijuana
taBLe 1 | Continued
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over time (61) and craving scores (53, 69), although the changes 
were not maintained at the 4-month follow-up (61). Moreover, 
MBRP participants showed significantly higher negative 
expectancies of drug use and decreased depressive mood 
(45, 53) and anxiety (53) as well as no association between 
craving and depressive symptoms when compared to TAU indi-
viduals, who evidenced a strong association between these two 
lastly mentioned variables (68). Another result of these trials 
was a tendency toward a greater acceptance and less judgment 
when measured with Acceptance and Action Questionnaire 
(82) and Five-Facet Mindfulness Questionnaire (83) in MBRP 
participants (69).
For its part, Luoma et al. (62) examined the effects of ACT on 
shame when compared with TAU. They confirmed that the more 
gradual reductions in shame in the ACT group protected against 
high levels of substance use, and this intervention led to higher 
levels of outpatient treatment attendance during follow-up and 
continuous treatment gains, especially on psychosocial meas-
ures. The combination of other types of MBIs and TAU showed a 
significant reduction of urges to drink (31), and a greater degree 
of mindfulness was associated with less nicotine dependence 
and less withdrawal severity (52, 58, 77). Furthermore, the 
combination of MBIs and TAU provided a high self-efficacy 
regarding one’s ability to abstain from smoking in high-risk situ-
ations (77) and less craving and drug use in response to social 
pressure (39). MBIs reduced dissociation, perceived stress, and 
emotion regulation difficulties in a women population (39) and 
decreased medical problems over time in a meditation group 
although without long-term effects (59). Furthermore, the 
combination of MBIs and TAU decreased the primary outcome 
measure of drug and alcohol craving and the impact of past 
trauma and disturbed sleep as well as increased mindfulness, 
self-compassion and well-being (38), and self-esteem (44).
Finally, McIntosh et  al. (63) explored the contribution of 
a MBIs  +  CBT for pathological gambling and whether the 
sequencing of these interventions impacted the effectiveness 
of the treatment (Mindfulness + CBT or CBT + Mindfulness). 
They found the combination of psychoeducation, mindfulness 
intervention, and CBT may be a useful complement of traditional 
CBT treatments, and it may be offered as an alternative treatment 
for gambling disorder to improve secondary dysfunction.
efficacy of mBis compared with cBt
While in treatment, participants in MBIs (e.g., MT) did not 
significantly differ from participants in CBT regarding treatment 
satisfaction, retention, or frequency of substance use, but MBI 
participants showed diminished physiological and psychological 
responses to stress provocation compared with the CBT group 
(19). In the study by Garland et al. (43), MORE intervention was 
associated with modest statistically significant improvements 
in post-traumatic stress symptoms, craving, and positive and 
negative affect from pre-to-post treatment versus the CBT group. 
Additionally, this intervention showed a significant indirect 
effect on craving and post-traumatic stress through increased 
dispositional mindfulness. In another study (78) that evaluated 
the efficacy of MBAT versus CBT and TAU, there were no sig-
nificant overall differences in abstinence rates across the three 
evaluate neurophysiologic alterations across the treatment. In 
another study (46), the health-related quality of life (HRQOL) 
was the primary outcome. Finally, Negrei et al. (35) investigated 
if the combination of mindfulness techniques and a CBT group 
protocol diminished the level of depression and anxiety among a 
population with addictions.
Secondary and Additional Outcomes
These included levels of emotion regulation, dispositional mind-
fulness, distress tolerance, psychiatric severity, event-related 
brain potentials, general health, and mood. The timing of the 
outcome measures was variable and could include weekly assess-
ment, post-treatment evaluation and 1, 2, 3, 4, 6, and 12-month 
follow-up evaluation. Sixteen studies did not report follow-up 
periods (20, 32, 33, 35, 38, 41–44, 46, 48, 57, 66, 67, 77, 81).
Attrition Rates
There was wide variability in the number of participants dropping 
out from MBIs with attrition rates ranging from 0 to 61% (median 
attrition = 23.765%). Some studies did not show attrition rates 
(31, 32, 35, 41, 42, 49, 54, 57, 60, 61, 63, 66, 67, 69, 72, 75).
DiScUSSiON
Overall, the revised literature shows the value of MBIs for reduc-
ing dependence, craving, and other addiction-related symptoms 
as well as improving depression, anxiety, and perceived stress 
and emotion regulation difficulties. Nevertheless, in the 
majority of the included trials, the MBI effects do not persist 
at follow-up assessment. In addition, studies seem to indicate 
that a combination of a mindfulness intervention together with 
TAU (including active treatments) would be the best treatment 
option. With regard to the effects of MBIs, it has been observed 
that the combination of different processes such as acceptance, 
awareness, and non-judgment is necessary to predict changes in 
craving (69).
efficacy of mBis compared with taU
In this review, several of the included studies compare MBIs 
with TAU. With regard to MBRP versus TAU, individuals who 
received MBRP and showed lower distress tolerance reported 
greater reductions in alcohol and other drugs use frequency 
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treatments. However, MBAT showed benefits over CBT and TAU 
in promoting recovery from a lapse among participants who 
were not abstinent at the end of treatment. Still, Azizi et al. (41) 
observed that the cognitive therapy and naltrexone treatment 
were fewer effective than the emotion regulation treatment. 
Nevertheless, both mindfulness and cognitive therapy showed 
an increment in other symptoms such as distress tolerance or 
emotion regulation, and a decrement in the amount of drug 
abuse, anxiety, somatic symptoms, social dysfunction, and 
depression in comparison with pharmacotherapy. Furthermore, 
the combination of mindfulness and CBT (35) produced lower 
scores in depression and anxiety compared to the medication 
group.
efficacy of mBis compared with RP
One of the trials that compared MBIs with RP (70) assessed the 
relative efficacy of MBRP, RP, and TAU on 12-month SUD out-
comes. MBRP and RP showed a decreased risk of relapse of drug 
and alcohol use. Compared with RP, the MBRP group showed 
an increased relapse risk of the first drug they used but RP and 
MBRP did not differ significantly on the time of the first heavy 
drinking. At the 3-month follow-up, no differences were found 
between groups; at the 6-month follow-up, RP and MBRP had a 
significantly reduced risk of drug use relapse and heavy drinking 
versus TAU, with an advantage in RP group over MBRP on the 
first drug use; and at the 12-month follow-up, MBRP reported 
significantly higher probability of not engaging in heavy drink-
ing and fewer drug use days compared with RP. These results 
partially coincide with those of Witkiewitz et al. (36, 37), who 
found lower addiction severity and less drug use at follow-up 
in MBRP group versus RP. In the study by Carroll (71), MBRP 
was significant and positively related to mindfulness, whereas 
RP was significant and inversely related to mindfulness and 
associated with higher levels of thought suppression. Moreover, 
MBRP produced psychophysiological responses against stress 
that suggest self-regulation and self-soothing behaviors instead 
of abusing substances.
efficacy of mBis compared with He
Mindfulness-Based Relapse Prevention and ART showed greater 
declines in negative affect (72, 76, 80), and MBRP is effective in 
reducing psychiatric severity (e.g., major depression and gen-
eralized anxiety disorder) as well as stimulant use among those 
with these health mental problems (72, 76). Stasiewicz et al. (80) 
found that the combination of CBT and ART demonstrated 
significantly greater increases of the percentage of abstinent 
days from the baseline to the tendency of treatment versus the 
combination CBT and HE even though this effect began to 
slightly decline during follow-up. Besides, MBIs (e.g., ACT) had 
neurophysiologic effects as the brain’s responsiveness to painful 
stimuli decreased in patients with chronic low back pain and 
opioid addiction comorbidity (66).
efficacy of mBis compared with Usual 
Smoking interventions
There was variability with respect to the control groups of the 
included smoking studies. MBIs (e.g., MTS) showed significant 
improvements on self-reported measures of attentional control, 
emotion regulation, and mindfulness. Post-treatment, these 
measures were significantly correlated with meditation time 
and smoking abstinence versus Quit Line intervention or FFS 
(55, 73, 74). In addition, this type of mindfulness intervention 
(MTS) produced lower neural reactivity stress in regions includ-
ing amygdala and insula (75).
When MTS was compared with ILS (50), there were no 
significant differences between groups in smoking abstinence 
although MTS participants showed significantly greater number 
of abstinence days in the first 2 weeks. With reference to alco-
hol use, controls significantly increased alcohol consumption 
over the course of the intervention, whereas MBI participants 
decreased consumption. For its part, in the study by Bricker et al. 
(64), a smartphone app-delivered ACT intervention for smoking 
cessation (SmartQuit) showed striking higher dropout rate versus 
a QuitGuide group control.
efficacy of mBis compared with SG
In a set of studies conducted by Garland et al. (20, 30, 56, 57), in 
which they compared MORE with a SG, they found stress and 
alcohol bias reduction and alcohol thought suppression as well 
as HRV recovery increase from alcohol cues following stress 
induction in MORE groups. Contrary to their hypotheses, MORE 
did not significantly increase self-reported mindfulness, nor did 
it result in significant decrements in craving, but significantly 
reduced symptoms associated with chronic pain and prescription 
opioid misuse.
efficacy of mBis compared with  
Non-treatment
Dixon et  al. (42) observed a neurological change in an ACT 
intervention toward similar brain activation patterns as non-
pathological gamblers, including activation in the middle 
frontal gyrus and inferior parietal lobule. Following treatment, 
ACT participants were more likely to report higher engagement 
in psychological flexibility and mindfulness-related behaviors. 
In another study targeting problem gamblers (79), MBIs 
reported significantly fewer gambling symptoms, gambling 
urges, and psychiatric symptoms at post-treatment, and they 
demonstrated that the mindfulness practice (measured by 
number of minutes) was significantly correlated with a reduction 
in psychiatric symptoms. MBIs versus no treatment have been 
associated with negative affect and urges (49), improvements 
in working memory, reflection-impulsivity/decision-making 
and performance, reduced stress levels and increased planning 
(81), decreased marijuana use at post-treatment and 3-month 
follow-up in a women population (40), and better HRQOL due 
to increased awareness of thoughts and emotions, acceptance, 
and compassion (46).
efficacy of mBis compared with  
Other interventions
Mindfulness-based interventions have been compared with 
numerous control interventions. With reference to yoga 
versus physical education, Butzer et  al. (47) concluded that 
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yoga has beneficial effects on emotional self-control (females) 
and willingness to smoke cigarettes (females and males). No 
differences between groups pre- to post-interventions were 
found although they observed improvements over an extended 
period of time.
In college students, MBIs compared with relaxation (34, 51, 
67) showed a significant smoking and craving reduction, an 
increased activity at inferior frontal gyrus/ventrolateral PFC 
and ACC/medial PFC and a decreased activity at cerebellum, 
posterior cingulated cortex/precuneus, and other regions after 
the intervention. Furthermore, MBIs were effective at increasing 
mindfulness state, and MBIs such as relaxation showed decreased 
negative affect and urge after interventions. However, higher lev-
els of some of the facets of impulsivity, such as Sensation seeking, 
Negative and Positive urgency were associated with increased 
negative affect and urge and decreased positive affect in the post-
mindfulness intervention.
When MBIs were compared to a distraction strategy or pas-
sive control or suppression condition (54, 65), there were no 
overall differences between groups. It seems that dispositional 
anxiety sensitivity did not have an impact on the outcomes 
but, state symptom-focused anxiety immediately after the cue 
induction procedure was a significant predictor of self-efficacy 
at follow-up. Specifically, and contrary to previous research, 
individuals who are anxiety sensitive do equally well, or better, 
when coping with cravings using a suppression-based approach 
as they do when using a mindfulness strategy, at least in the 
short term.
LimitatiONS
The systematic review reported here intent to show MBIs’ results 
and effects. The main limitation of this review is that the patient 
population, MBIs, comparators, and outcome measures are not 
the same across studies. Moreover, the quality was adequate in 
all studies. Another limitation of our study is the number of tri-
als included in the review, 54, and the consequent difficulty to 
integrate all information. However, for solving this problem we 
used five reviewers.
cONcLUSiON aND FUtURe 
PeRSPectiveS
The revised literature gives support to the effectiveness of the 
MBIs. These treatments are adequate to reduce dependence, 
craving, and other addiction-related symptoms as well as to 
improve mood state and emotion dysregulation. There are cer-
tain interventions that presented better results in the treatment 
of addiction such as MBRP, MTS, or MORE. Nevertheless, the 
best effectiveness may be the combination of the MBIs with TAU 
or another active treatment. Besides, few studies have found 
maintenance of the effects over time, and it would be important 
to conduct more follow-up studies. As for the target popula-
tion, it would be interesting to investigate addiction problems 
in adolescents and young adults because they are a fragile and 
sensitive population to develop special interests in drugs and 
other addictions.
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